Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer
WB Ershler - The Oncologist, 2006 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the pharmacology of capecitabine. Discuss the use of capecitabine as a single …
Describe the pharmacology of capecitabine. Discuss the use of capecitabine as a single …
[HTML][HTML] Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines
JSJ Lim, SGW Ow, ALA Wong, MXW Lee… - European Journal of …, 2023 - Elsevier
Background Fluoropyrimidines are commonly used in the treatment of metastatic breast
cancer (MBC), and trifluridine/tipiracil (FTD/TPI) has shown activity in patients with colorectal …
cancer (MBC), and trifluridine/tipiracil (FTD/TPI) has shown activity in patients with colorectal …
[PDF][PDF] Efficacy and safety profile of capecitabine-based regimens in women with metastatic breast cancer
AS Nayyef, AM Jawad - oncologyjournal.in
Background: Breast cancer is the most frequent cancer in women and the leading cause of
cancer deaths. The major treatment for metastatic hormone receptor–negative breast cancer …
cancer deaths. The major treatment for metastatic hormone receptor–negative breast cancer …
[PDF][PDF] Монотерапия капецитабином: эффективное и безопасное лечение метастатического рака молочной железы
WB Ershler - The Oncologist, 2006 - omnidoctor.ru
РМЖ, у которых предшествующая антрациклинсодержащая терапия оказалась
неэффективной. Стандартный режим дозирования составляет 1250 мг/м2 перорально …
неэффективной. Стандартный режим дозирования составляет 1250 мг/м2 перорально …